Cholesterol is one of the most commonly measured markers in medicine — and one of the most misunderstood. Patients are often told their cholesterol is "a bit high" without being given a clear explanation of what that means, which number is the problem, or what the clinical implications are. According to the Health Survey for England 2021, 59% of UK adults have raised total cholesterol — defined as above 5.0 mmol/L — yet the majority have no symptoms and are unaware of their cardiovascular risk[1].
Understanding your cholesterol numbers is not simply a matter of knowing whether a figure is above or below a threshold. It requires understanding the relationship between different lipid fractions, your overall cardiovascular risk profile, and the evidence-based targets that apply to your individual situation. This guide explains each number, what the current NICE guidance recommends, and when to seek further assessment from a private GP or cardiologist.
1. What Is Cholesterol and Why Does It Matter?
Cholesterol is a waxy, fat-like substance produced by the liver and obtained from dietary sources. It is essential for the production of cell membranes, steroid hormones, bile acids, and vitamin D. The body regulates cholesterol production carefully — when dietary intake is high, hepatic synthesis decreases, and vice versa. However, in a significant proportion of the population, this regulatory mechanism is insufficient to maintain optimal levels, particularly in the presence of genetic predisposition, dietary excess, or metabolic disease.
Cholesterol is transported in the bloodstream by lipoproteins — protein-lipid complexes that vary in density and function. The clinically important fractions are low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very-low-density lipoprotein (VLDL, which carries triglycerides). Each fraction has a distinct relationship with cardiovascular risk, and understanding the difference between them is essential for interpreting a lipid panel result.
Higher LDL cholesterol is one factor that can contribute to atherosclerotic cardiovascular disease over time. A result needs to be considered with the wider cardiovascular-risk picture rather than used alone to predict what will happen to one person.[2]
2. Understanding Your Cholesterol Numbers
A lipid profile commonly reports total cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides; some reports also include LDL cholesterol. The figures contribute to cardiovascular-risk assessment alongside other information, including age, blood pressure and health conditions.[NHS]
| Lipid Fraction | What It Measures | NHS guide for healthy adults | How it is used |
|---|---|---|---|
| Total cholesterol | The overall amount of cholesterol in the blood | Below 5 mmol/L | One part of a wider risk assessment |
| HDL cholesterol | Often called ‘good’ cholesterol | Above 1 mmol/L (men); above 1.2 mmol/L (women) | Interpreted alongside other lipids and risk factors |
| Non-HDL cholesterol | Total cholesterol minus HDL cholesterol | Below 4 mmol/L | Can help inform a cardiovascular-risk discussion |
| LDL cholesterol | A cholesterol-carrying lipoprotein | No single public guide applies to every person | May be considered with the full lipid profile |
| Triglycerides | A type of fat measured in a lipid profile | No single result should be interpreted in isolation | May prompt a clinician to consider context or a repeat test |
| Total:HDL ratio | Total cholesterol divided by HDL cholesterol | No universal personal target | May be used within a risk calculation |
3. NICE Cholesterol Targets: Primary vs Secondary Prevention
NICE Guideline NG238 (December 2023) distinguishes between primary prevention — reducing the risk of a first cardiovascular event in people without established cardiovascular disease — and secondary prevention — reducing the risk of a further event in people who have already had a heart attack, stroke, or are diagnosed with coronary artery disease[2].
The targets differ significantly between these two groups. For secondary prevention, the evidence supports more aggressive lipid lowering — the NICE target is LDL cholesterol ≤ 2.0 mmol/L or non-HDL cholesterol ≤ 2.6 mmol/L. For primary prevention, the approach is risk-based: a 10-year QRISK3 score is calculated, and statin therapy is recommended if the 10-year cardiovascular risk exceeds 10%, with a treatment goal of ≥40% reduction in non-HDL cholesterol[3].
| Prevention Type | Clinical context | Assessment approach | What to discuss |
|---|---|---|---|
| Primary prevention | No established cardiovascular disease | QRISK3 may help structure a 10-year risk discussion for eligible adults | The result, wider risk factors, benefits, harms and preferences |
| Established cardiovascular disease | Previous cardiovascular disease or an existing secondary-prevention plan | Follow the individualised secondary-prevention pathway | Treatment, monitoring and risk reduction with the responsible clinician |
| Possible familial hypercholesterolaemia | Markedly raised lipids or relevant family history | Assess against the NICE familial hypercholesterolaemia pathway | Whether specialist review or further testing is appropriate |
| Type 2 diabetes or kidney disease | Conditions that can change cardiovascular risk | Use the relevant condition-specific guidance and clinical judgement | How the lipid profile fits with the broader care plan |
4. What Causes High Cholesterol?
High cholesterol can have modifiable and non-modifiable contributors. A clinician may consider the lipid profile, medical history, medicines, family history and possible secondary causes before discussing whether lifestyle support, further assessment or treatment is appropriate.
| Category | Cause | Modifiable? |
|---|---|---|
| Genetic | Possible familial or polygenic lipid disorders | May require assessment through an inherited-lipid pathway |
| Dietary and lifestyle | Dietary pattern, activity, weight and alcohol intake | May form part of an individual risk-reduction plan |
| Metabolic | Diabetes and insulin resistance | May be considered alongside glucose control and other risk factors |
| Thyroid | Hypothyroidism | A possible secondary cause that may need assessment |
| Kidney or liver conditions | Chronic kidney disease or liver disease | The relevant condition-specific care plan may affect interpretation |
| Medicines | Some medicines can affect lipid levels | A medication review may be appropriate; do not alter prescribed medicines without advice |
| Age, sex and family history | Factors that can affect overall cardiovascular risk | Used as part of the wider risk discussion |
Familial hypercholesterolaemia is an inherited lipid disorder that may be considered where there are markedly raised lipid results or a relevant family history. NICE advises using clinical findings, a full lipid profile and family history rather than strict cut-off values alone when judging whether an inherited lipid disorder is likely.[2] A clinician can advise whether a lipid profile, further assessment or a specialist pathway is appropriate.
5. Symptoms of High Cholesterol — and Why Most People Have None
High cholesterol commonly has no symptoms. Symptoms such as chest pain, breathlessness or neurological changes have many possible causes and should not be used to self-diagnose the effect of a cholesterol result. New, severe or concerning symptoms need prompt clinical assessment.
Some physical signs can be associated with severe inherited lipid disorders, but their presence or absence does not diagnose or exclude high cholesterol. A lipid profile can provide relevant information where testing is clinically appropriate; the clinic confirms suitability, preparation, reporting and follow-up arrangements at booking.
Symptoms that require urgent assessment
High cholesterol itself does not cause acute symptoms. However, the cardiovascular events it causes — heart attack and stroke — are medical emergencies. Call 999 immediately if you experience:
- Severe chest pain, pressure, or tightness — especially radiating to the arm, jaw, or back
- Sudden weakness or numbness on one side of the face, arm, or leg
- Sudden difficulty speaking, understanding speech, or confusion
- Sudden severe headache with no known cause
- Sudden loss of vision in one or both eyes
6. What Tests Are Used to Assess Cholesterol and Cardiovascular Risk?
A lipid profile is often used when cholesterol is being assessed. NICE advises that non-fasting lipid measurements can be used for initial cardiovascular-risk assessment in many situations, while fasting or further testing may be considered where clinically relevant.[2] The clinic confirms test selection, preparation, availability, reporting and follow-up arrangements for the selected pathway at booking.
| Investigation | What It Assesses | When Ordered |
|---|---|---|
| Lipid profile | Cholesterol fractions and triglycerides | May be used where cholesterol assessment is appropriate |
| QRISK3 calculation | An estimate of 10-year cardiovascular risk for eligible adults | May support, but does not replace, clinical judgement |
| Thyroid function | A possible secondary contributor to an altered lipid profile | May be considered where indicated by the clinical picture |
| HbA1c or glucose | Possible diabetes-related risk factors | May be considered with other metabolic risk information |
| Liver or kidney tests | Conditions or treatment factors relevant to the wider assessment | Chosen if clinically appropriate |
| Lipoprotein(a) | An inherited cardiovascular-risk factor | May be considered within a specialist or risk-assessment pathway |
| ECG or echocardiogram | Different aspects of cardiac electrical activity or structure | Not routine cholesterol tests; used only when symptoms or clinical findings warrant |
7. When to See a GP or Cardiologist About Your Cholesterol
Not every elevated cholesterol result requires an urgent specialist appointment. The appropriate response depends on the level of elevation, the presence of other cardiovascular risk factors, and whether you have established cardiovascular disease. The following framework helps clarify when each level of care is appropriate.
See a GP when:
- You have a lipid result you do not understand or want to discuss in context
- You have a family history of early cardiovascular disease or possible familial hypercholesterolaemia
- You have diabetes, high blood pressure, kidney disease or other cardiovascular risk factors
- You are taking lipid-lowering treatment and need an agreed review plan
- You would like to discuss whether a QRISK3 assessment is relevant to you
See a cardiologist when:
- A clinician identifies a possible inherited lipid disorder or complex cardiovascular-risk picture
- You have established cardiovascular disease and need advice within your existing care pathway
- You have cardiac symptoms, particularly if they are new, severe or concerning
- Your clinician considers specialist lipid or cardiology input appropriate
Frequently Asked Questions
What is a normal cholesterol level in the UK?
The NHS publishes guide levels for healthy adults, but there is no single ‘normal’ cholesterol result that applies to everyone. Results are considered alongside factors such as age, blood pressure, medical history and smoking status. QRISK3 may be used for eligible adults as part of that discussion, but it does not predict an individual outcome.
Do I need to fast before a cholesterol blood test?
Not always. NICE states that non-fasting measurements can be used for initial cardiovascular-risk assessment in many situations. The appropriate preparation depends on the reason for testing and the clinical context, so the clinic confirms it at booking.
Can high cholesterol be treated without statins?
Sometimes, but not for everyone. Dietary pattern, physical activity, weight management and other lifestyle changes may form part of a lipid-management plan. Their likely role, and whether medication should be considered, depend on lipid results, overall cardiovascular risk, family history, medical history and current guidance. A clinician can discuss the appropriate options and follow-up for your circumstances.
What is the difference between LDL and HDL cholesterol?
LDL and HDL are different cholesterol-carrying lipoproteins. Their values are interpreted with the rest of the lipid profile and the person’s broader cardiovascular-risk factors. A result should not be used alone to diagnose disease or determine a treatment target.
How quickly can I get a cholesterol blood test in London?
The clinic confirms whether a fasting or non-fasting lipid panel is appropriate, along with availability, reporting and follow-up arrangements, at booking. The clinic is at 170 Vauxhall Bridge Road, Victoria SW1, two minutes from Victoria Station.
What is familial hypercholesterolaemia and how is it diagnosed?
Familial hypercholesterolaemia is an inherited lipid disorder. NICE advises assessment using a full lipid profile, family history and clinical findings; further testing or specialist referral may be considered where appropriate. Management is tailored through the relevant clinical pathway rather than determined by a webpage.
Related Guides
High Blood Pressure: Symptoms, Causes, and When to See a Doctor
Hypertension and high cholesterol frequently co-exist and amplify each other's cardiovascular risk. Dr Xynopoulos explains the NICE classification, causes, and when to see a cardiologist.
Heart Palpitations: Causes, When to Worry, and What Tests You Need
Palpitations can be a symptom of the cardiovascular complications of untreated hypercholesterolaemia. This guide explains causes, red flags, and which tests provide answers.
Private Blood Tests in London
A full lipid panel, HbA1c, thyroid function and cardiovascular risk markers — with the appropriate test selection and pathway confirmed at booking.
Private GP vs NHS GP: What Are the Key Differences?
Understanding the difference between NHS and private GP care — including how cholesterol and cardiovascular risk are managed in each system.
References
- [1] NHS Digital. Health Survey for England 2021: Adult Health — Cholesterol. NHS England. 2023. https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2021-part-2/adult-health-cholesterol
- [2] National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE Guideline NG238. December 2023. https://www.nice.org.uk/guidance/ng238
- [3] Williams E, Sheringham J, et al. Cardiovascular disease risk assessment and reduction: NICE 2023 update for GPs. Br J Gen Pract. 2024;74(748):523–525. https://bjgp.org/content/74/748/523
- [4] Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596–e646. https://www.ahajournals.org/doi/10.1161/cir.0000000000000678
- [5] Durand A, Sheringham J, et al. Familial hypercholesterolaemia in UK primary care: a Clinical Practice Research Datalink study. BMC Cardiovasc Disord. 2024;24(1):95. https://pmc.ncbi.nlm.nih.gov/articles/PMC10877619/
- [6] Allan GM, Garrison S, McCormack J. Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care. Can Fam Physician. 2015;61(10):857–867. https://pmc.ncbi.nlm.nih.gov/articles/PMC4607330/
Know Your Cholesterol Numbers Today
The clinic can explain the appropriate lipid testing and cardiovascular assessment pathway, including availability, reporting and follow-up arrangements, at booking.